Landogrozumab (MSTN/GDF8) - Research Grade Biosimilar
Product Specifications
Background
Landogrozumab has been used in trials studying the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.
Immunogen
Humanized / MSTN/GDF8 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-746
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
LY-2495655
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CSB-RP027154h-01 20 µg
Recombinant Human Zinc finger BED domain-containing protein 1 (ZBED1), partial
Ask
View Details CSB-RP027154h-02 100 µg
Recombinant Human Zinc finger BED domain-containing protein 1 (ZBED1), partial
Ask
View Details 
CSB-RP027154h-03 1 mg
Recombinant Human Zinc finger BED domain-containing protein 1 (ZBED1), partial
Ask
View Details